Gallo D - Search Results

1

A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer.

Buttarelli M, Babini G, Raspaglio G, Filippetti F, Battaglia A, Ciucci A, Ferrandina G, Petrillo M, Marino C, Mancuso M, Saran A, Villani ME, Desiderio A, D'Ambrosio C, Scaloni A, Scambia G, Gallo D. Buttarelli M, et al. Among authors: gallo d, d ambrosio c. J Exp Clin Cancer Res. 2019 Jun 26;38(1):279. doi: 10.1186/s13046-019-1268-y. J Exp Clin Cancer Res. 2019. PMID: 31242951 Free PMC article.

2

Antitumor activity of paclitaxel (taxol) analogues on MDR-positive human cancer cells.

Distefano M, Scambia G, Ferlini C, Gallo D, De Vincenzo R, Filippini P, Riva A, Bombardelli E, Mancuso S. Distefano M, et al. Among authors: gallo d. Anticancer Drug Des. 1998 Jul;13(5):489-99. Anticancer Drug Des. 1998. PMID: 9702212

3

Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer.

Gallo D, Ferlini C, Distefano M, Cantelmo F, Gaggini C, Fattorossi A, Riva A, Bombardelli E, Proietti E, Mancuso S, Scambia G. Gallo D, et al. Cancer Chemother Pharmacol. 2000;45(2):127-32. doi: 10.1007/s002800050020. Cancer Chemother Pharmacol. 2000. PMID: 10663627

4

Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy.

Gallo D, Giacomelli S, Cantelmo F, Zannoni GF, Ferrandina G, Fruscella E, Riva A, Morazzoni P, Bombardelli E, Mancuso S, Scambia G. Gallo D, et al. Breast Cancer Res Treat. 2001 Sep;69(2):153-64. doi: 10.1023/a:1012414119944. Breast Cancer Res Treat. 2001. PMID: 11759821

5

Dietary soy modulation of biochemical parameters in DMBA-induced mammary tumors.

Gallo D, Ferrandina G, Giacomelli S, Fruscella E, Zannoni G, Morazzoni P, Riva A, Bombardelli E, Mancuso S, Scambia G. Gallo D, et al. Cancer Lett. 2002 Dec 1;186(1):43-8. doi: 10.1016/s0304-3835(02)00326-9. Cancer Lett. 2002. PMID: 12183074

6

Second generation taxanes: from the natural framework to the challenge of drug resistance.

Ferlini C, Ojima I, Distefano M, Gallo D, Riva A, Morazzoni P, Bombardelli E, Mancuso S, Scambia G. Ferlini C, et al. Among authors: gallo d. Curr Med Chem Anticancer Agents. 2003 Mar;3(2):133-8. doi: 10.2174/1568011033353489. Curr Med Chem Anticancer Agents. 2003. PMID: 12678907 Review.

7

Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance.

Ferlini C, Raspaglio G, Mozzetti S, Distefano M, Filippetti F, Martinelli E, Ferrandina G, Gallo D, Ranelletti FO, Scambia G. Ferlini C, et al. Among authors: gallo d. Mol Pharmacol. 2003 Jul;64(1):51-8. doi: 10.1124/mol.64.1.51. Mol Pharmacol. 2003. PMID: 12815160

8

Antitumour activity of the silybin-phosphatidylcholine complex, IdB 1016, against human ovarian cancer.

Gallo D, Giacomelli S, Ferlini C, Raspaglio G, Apollonio P, Prislei S, Riva A, Morazzoni P, Bombardelli E, Scambia G. Gallo D, et al. Eur J Cancer. 2003 Nov;39(16):2403-10. doi: 10.1016/s0959-8049(03)00624-5. Eur J Cancer. 2003. PMID: 14556934

9

Gemcitabine: current role and future options in the treatment of ovarian cancer.

Fruscella E, Gallo D, Ferrandina G, D'Agostino G, Scambia G. Fruscella E, et al. Among authors: d agostino g, gallo d. Crit Rev Oncol Hematol. 2003 Oct;48(1):81-8. doi: 10.1016/s1040-8428(03)00119-7. Crit Rev Oncol Hematol. 2003. PMID: 14585485 Review.

10

Thiocolchicine dimers: a novel class of topoisomerase-I inhibitors.

Raspaglio G, Ferlini C, Mozzetti S, Prislei S, Gallo D, Das N, Scambia G. Raspaglio G, et al. Among authors: gallo d. Biochem Pharmacol. 2005 Jan 1;69(1):113-21. doi: 10.1016/j.bcp.2004.09.004. Biochem Pharmacol. 2005. PMID: 15588720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

668 results

Search Page